In our study, we made a novel observation regarding the high expression of Suppressyn (ERVH48-1, HGCN: 17216) and Syncytin-2 (ERVFRD-1, HGCN: 33823) in AML, which showed significant survival differences. This evidence concerns the gene ERVFRD-1 and acute myeloid leukemia.